Drug Discovery Platforms Cooperation Division
- Main Research Fields :
- Biology
- Related Research Fields :
- Chemistry
- Keywords :
- Chemical Biology / Epigenetics / Mode of Action / Transcriptional Regulation / Chemical Screening for Drug Discovery
- Project :
- Drug Discovery Platforms Cooperation Division
D
Discovery of seed/lead compounds by HTS and medicinal chemistry for development of new drugs
Division Director
CONTACT
RIKEN Center for Sustainable Resource Science
Drug Discovery Platforms Cooperation Division
yoshidam
Related Links
Laboratory on RIKEN Website
Drug Discovery Platforms Cooperation Division | RIKEN
Outline
The increased availability of genomic sequence information has already allowed the identification of numerous novel drug targets. The next challenge lies in developing new technology and assays, to further expand and exploit available genomic information obtained from basic research, and begin translational programs that will lead towards actual application and patient treatment. Academic drug discovery has become a world-wide movement at universities and research institutions, in response to which the RIKEN launched the Drug Discovery and Medical Technology Platforms (DMP). Capitalizing on RIKEN’s excellent track record in basic science and technology, including a vast library of bioactive natural products, state of the art equipment for high throughput screening (HTS), and medicinal chemistry for hit-to-lead and lead optimization, our division aims at making innovative contributions to the academic drug discovery effort.Teams / Units
-
- Drug Discovery Chemical Bank Unit
- Unit Leader:
- Hiroyuki Osada
-
- Drug Discovery Seed Compounds Exploratory Unit
- Unit Leader:
- Minoru Yoshida
-
- Drug Discovery Chemistry Platform Unit
- Unit Leader:
- Hiroo Koyama
-
